Literature DB >> 12974552

Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics.

J T Mortensen1, J Olsen, H Larsen, J Bendsen, C Obel, H T Sørensen.   

Abstract

We did a follow-up study based upon a regional prescription register in Denmark. We identified all 435 women who in the period 1991-1996 had redeemed a prescription for CNS drugs during pregnancy. Among the rest of the pregnant women we randomly selected 1304 women who also had given birth to a child in the same region and period. We looked up the local health nurses Boel test results which were available for about 80%. Any abnormal test result was seen much more frequently among exposed (16%) than for not exposed (4%). The study has several limitations but raises concern that should be addressed in other and better designed studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12974552     DOI: 10.1023/a:1025306304635

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  17 in total

1.  Association Between Antidepressants Use During Pregnancy and Autistic Spectrum Disorders: A Meta-analysis.

Authors:  Theodor B Rais; Alexandra Rais
Journal:  Innov Clin Neurosci       Date:  2014-05

2.  Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.

Authors:  Regina C Casper; Allyson A Gilles; Barry E Fleisher; Joan Baran; Gregory Enns; Laura C Lazzeroni
Journal:  Psychopharmacology (Berl)       Date:  2011-04-16       Impact factor: 4.530

3.  Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006.

Authors:  Anders Engeland; Jørgen G Bramness; Anne Kjersti Daltveit; Marit Rønning; Svetlana Skurtveit; Kari Furu
Journal:  Br J Clin Pharmacol       Date:  2008-02-20       Impact factor: 4.335

Review 4.  Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review.

Authors:  Hanan El Marroun; Tonya White; Frank C Verhulst; Henning Tiemeier
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-05-27       Impact factor: 4.785

5.  Atropinic burden of drugs during pregnancy and psychological development of children: a cohort study in the EFEMERIS database.

Authors:  Anna-Belle Beau; Jean-Louis Montastruc; Isabelle Lacroix; François Montastruc; Caroline Hurault-Delarue; Christine Damase-Michel
Journal:  Br J Clin Pharmacol       Date:  2016-05-29       Impact factor: 4.335

Review 6.  SSRIs in pregnancy and lactation: emphasis on neurodevelopmental outcome.

Authors:  Salvatore Gentile
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 7.  Perinatal depression: treatment options and dilemmas.

Authors:  Teri Pearlstein
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

Review 8.  A review of environmental contributions to childhood motor skills.

Authors:  Jean Golding; Pauline Emmett; Yasmin Iles-Caven; Colin Steer; Raghu Lingam
Journal:  J Child Neurol       Date:  2013-10-29       Impact factor: 1.987

Review 9.  Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.

Authors:  Rebecca Bromley; Jennifer Weston; Naghme Adab; Janette Greenhalgh; Anna Sanniti; Andrew J McKay; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2014-10-30

10.  The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring.

Authors:  J D A Olivier; H Akerud; H Kaihola; J L Pawluski; A Skalkidou; U Högberg; I Sundström-Poromaa
Journal:  Front Cell Neurosci       Date:  2013-05-21       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.